Novavax COVID-19 vaccine now available in Michigan

Published: Aug. 12, 2022 at 6:13 PM EDT
Email This Link
Share on Pinterest
Share on LinkedIn

LANSING, Mich. (WNDU) - Michigan residents ages 18 and older now have another COVID-19 vaccine option.

On July 13, the FDA issued an emergency use authorization for the Novavax COVID-19 vaccine for two doses that are three-to-eight weeks apart.

There is currently no booster dose authorized for the vaccine at this time.

Press Release from the Michigan Department of Health and Human Services:

Michigan residents ages 18 and older now have another COVID-19 vaccine option – Novavax – to help protect them from serious illness and death due to the virus.

On July 13, the U.S. Food and Drug Administration issued an Emergency Use Authorization for Novavax COVID-19 vaccine for use among people ages 18 years and older for a two-dose primary series. This was followed by Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices’ recommendation for use of the Novavax COVID-19 vaccine in this population and endorsement by CDC.

“Having multiple types of vaccine offers more options and flexibility for people receiving COVID-19 vaccines,” said Dr. Natasha Bagdasarian, MDHHS chief medical executive. “COVID-19 vaccines remain our best defense against the virus, helping prevent serious illness and death. We continue to urge Michiganders who have not yet been vaccinated to get the vaccine as soon as possible.”

The Novavax COVID-19 vaccine is the first COVID-19 protein subunit vaccine recommended for use in the United States. During clinical trials, it was found to be over 90% effective in preventing serious illness from COVID-19. Adults ages 18 years and older should receive a two-dose primary series separated by three to eight weeks. A shorter interval of three weeks between the first and second doses is recommended for:

  • People who are moderately or severely immunocompromised.
  • Adults ages 65 years and older.
  • In situations in which there is increased concern about COVID-19 community levels or an individual’s higher risk of severe disease.

Currently, a booster dose using any COVID-19 vaccine is not authorized for adults in this age group who receive a Novavax primary series. A limited number of doses of Novavax COVID-19 vaccine will be distributed and not all providers are expected to carry Novavax COVID-19 vaccine. In Michigan, about 100,000 doses are available for order by vaccine providers. To locate providers offering Novavax, visit

To date, over 6.7 million Michiganders ages 5 and up have gotten at least their first dose of safe and effective COVID-19 vaccines. Eligible Michiganders are encouraged to stay up to date on vaccinations, which includes booster doses that provide extra protection, and residents of long-term care facilities where outbreaks can spread quickly and extra protection is strongly recommended.

MDHHS also encourages Michigan residents to pay attention to local guidance as some communities may be at a higher risk of COVID-19 transmission.

To schedule a primary or booster dose of the COVID vaccine, visit

To learn more about the COVID-19 vaccine, visit

For more information about COVID-19 in Michigan, visit

# # #

Additional Novavax resources:

Copyright 2022 WNDU. All rights reserved.

Latest News

Latest News